cutaneous - Health Topics
Yahoo Finance: Biogen to Present New Late-Breaking Litifilimab Phase 2 AMETHYST Data in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting Late-breaking AMETHYST Part A study results to be presented, showing safety and efficacy of litifilimab in cutaneous lupus erythematosus (CLE)Litifilimab was recently granted Breakthrough Therapy ... Biogen to Present New Late-Breaking Litifilimab Phase 2 AMETHYST Data in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting Perianal disease involvement and a history of an ostomy are associated with increased odds of developing metastatic cutaneous Crohn’s disease. Managed Healthcare Executive: Pazopanib shows promise as second-line option in rare cutaneous angiosarcoma Paclitaxel remains first-line for cutaneous angiosarcoma, but absence of validated second-line therapy creates a major unmet need after progression or intolerance.
Understanding the Context
A 30-patient, 15-center JCOG study ... Healio: Dupilumab treatment for atopic dermatitis linked to cutaneous T-cell lymphoma development Please provide your email address to receive an email when new articles are posted on . Dupilumab-treated patients with AD were 4.1003 times more likely to develop cutaneous T-cell lymphoma vs. those ...
Image Gallery
Key Insights
Yahoo Finance: Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant ... Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant ... Cutaneous larva migrans is caused by the epidermal migration of the filariform larvae of various hookworm and occasionally, dog tapeworm, species. The most common type is due to the dog/cat hookworm ... The New England Journal of Medicine: Cutaneous Electroanalgesia for Relief of Chronic and Neuropathic Pain